# A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score

> **NCT06279338** · NA · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 40 (estimated)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Azacitidine Injection

## Key facts

- **NCT ID:** NCT06279338
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06279338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06279338, "A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06279338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*